CDB-4124 and its putative monodemethylated metabolite, CDB-4453, are potent antiprogestins with reduced antiglucocorticoid activity: in vitro comparison to mifepristone and CDB-2914

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302 · see citing works

The Partial Agonist Activity of Antagonist-Occupied Steroid Receptors Is Controlled by a Novel Hinge Domain-Binding Coactivator L7/SPA and the Corepressors N-CoR or SMRT

Jackson, T. A., Richer, J. K., Bain, D. L., Takimoto, G. S., Tung, L. W., & Horwitz, K. B. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.6.0004 · Cited by 479 · see citing works

RU486 (MIFEPRISTONE): Mechanisms of Action and Clinical Uses

Cadepond, F., Ulmann, A., & Baulieu, E. E. (1997) · Annual Review of Medicine · doi:10.1146/annurev.med.48.1.129 · Cited by 424 · see citing works

The Opposing Transcriptional Activities of the Two Isoforms of the Human Progesterone Receptor Are Due to Differential Cofactor Binding

Giangrande, P. H., Kimbrel, E. A., Edwards, D. P., & McDonnell, D. P. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.9.3102-3115.2000 · Cited by 377 · see citing works

The Nuclear Corepressors NCoR and SMRT Are Key Regulators of Both Ligand- and 8-Bromo-Cyclic AMP-Dependent Transcriptional Activity of the Human Progesterone Receptor

Wagner, B. L., Norris, J. D., Knotts, T. A., Weigel, N. L., & McDonnell, D. P. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.3.1369 · Cited by 255 · see citing works

The assay of progestin

McPhail, M. K. (1934) · The Journal of Physiology · doi:10.1113/jphysiol.1934.sp003217 · Cited by 249 · see citing works

The progesterone antagonist RU486 acquires agonist activity upon stimulation of cAMP signaling pathways.

Beck, C. A., Weigel, N. L., Moyer, M. L., Nordeen, S. K., & Edwards, D. P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.10.4441 · Cited by 205 · see citing works

New steroids with antiprogestational and antiglucocorticoid activities

Neef, G., Beier, S., Elger, W. A. G., Henderson, D. A., & Wiechert, R. (1984) · Steroids · doi:10.1016/s0039-128x(84)80027-6 · Cited by 183 · see citing works

Antagonist-occupied human progesterone receptors bound to DNA are functionally switched to transcriptional agonists by cAMP

Sartorius, C. A., Tung, L. W., Takimoto, G. S., & Horwitz, K. B. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98344-4 · Cited by 176 · see citing works

Progesterone antagonists and progesterone receptor modulators in the treatment of breast cancer

Klijn, J. G. M. (2000) · Steroids · doi:10.1016/s0039-128x(00)00195-1 · Cited by 157 · see citing works

The rabbit progesterone receptor. Evidence for a single steroid-binding subunit and characterization of receptor mRNA.

Loosfelt, H., Logeat, F., Hai, M. T. V., & Milgröm, E. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89877-5 · Cited by 141 · see citing works

The Antiprogestin RU38 486: Receptor-Mediated ProgestinVersusAntiprogestin Actions Screened in Estrogen-Insensitive T47DCOHuman Breast Cancer Cells*

Horwitz, K. B. (1985) · Endocrinology · doi:10.1210/endo-116-6-2236 · Cited by 130 · see citing works

Latent agonist activity of the steroid antagonist, RU486, is unmasked in cells treated with activators of protein kinase A.

Nordeen, S. K., Bona, B. J., & Moyer, M. L. (1993) · Molecular Endocrinology · doi:10.1210/mend.7.6.8395651 · Cited by 108 · see citing works

Characterization and Functional Properties of the A and B Forms of Human Progesterone Receptors Synthesized in a Baculovirus System

Christensen, K. D., Estes, P. A., Oñate, S. A., Beck, C. A., Marzo, A. M. D., Altmann, M., Lieberman, B. A., John, J. S., Nordeen, S. K., & Edwards, D. P. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-11-1755 · Cited by 105 · see citing works

Modulation of cell signaling pathways can enhance or impair glucocorticoid-induced gene expression without altering the state of receptor phosphorylation.

Moyer, M. L., Borror, K. C., Bona, B. J., DeFranco, D. B., & Nordeen, S. K. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41616-x · Cited by 101 · see citing works

Synthesis and Biological Activity of a Novel, Highly Potent Progesterone Receptor Antagonist

Fuhrmann, U., Hess‐Stumpp, H., Cleve, A., Neef, G., Schwede, W., Hoffmann, J., Fritzemeier, K., & Chwalisż, K. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm001000c · Cited by 99 · see citing works

The coupling of multiple signal transduction pathways with steroid response mechanisms.

Nordeen, S. K., Moyer, M. L., & Bona, B. J. (1994) · Endocrinology · doi:10.1210/endo.134.4.8137736 · Cited by 91 · see citing works

History and perspectives of antiprogestins from the chemist's point of view

Teutsch, G., & Philibert, D. (1994) · Human Reproduction · doi:10.1093/humrep/9.suppl_1.12 · Cited by 86 · see citing works

Antiprogestins: Mechanism of Action and Contraceptive

Spitz, I. M., Croxatto, H. B., & Robbins, A. (1996) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.000403 · Cited by 82 · see citing works

The Novel Progesterone Receptor Antagonists RTI 3021-012 and RTI 3021-022 Exhibit Complex Glucocorticoid Receptor Antagonist Activities: Implications for the Development of Dissociated Antiprogestins

Wagner, B. L., Pollio, G., Giangrande, P. H., Webster, J. C., Breslin, M. B., Mais, D. E., Cook, C. E., Vedeckis, W. V., Cidlowski, J. A., & McDonnell, D. P. (1999) · Endocrinology · doi:10.1210/endo.140.3.6581 · Cited by 71 · see citing works

EFFECT OF LOCAL APPLICATION OF PROGESTERONE ON THE RABBIT UTERUS

McGinty, D. A., Anderson, L., & McCullough, N. B. (1939) · Endocrinology · doi:10.1210/endo-24-6-829 · Cited by 66 · see citing works

Mechanism of action of an antiprogesterone, RU486, in the rabbit endometrium

Rauch, M., Loosfelt, H., Philibert, D., & Milgröm, E. (1985) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1985.tb08827.x · Cited by 66 · see citing works

Progesterone receptor modulators and progesterone antagonists in women's health

Spitz, I. M. (2000) · Steroids · doi:10.1016/s0039-128x(00)00194-x · Cited by 62 · see citing works

New antiprogestins with partial agonist activity: potential selective progesterone receptor modulators (SPRMs) and probes for receptor- and coregulator-induced changes in progesterone receptor induction properties.

Giannoukos, G., Szapary, D., Smith, C. L., Meeker, J. E. W., & Simons, S. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.2.0596 · Cited by 51 · see citing works

CDB-2914: Anti-progestational/anti-glucocorticoid profile and post-coital anti-fertility activity in rats and rabbits

Hild, S. A. (2000) · Human Reproduction · doi:10.1093/humrep/15.4.822 · Cited by 46 · see citing works

Screening of anti-progestagens by receptor studies and bioassays

Kloosterboer, H. J., Deckers, G. H., van der Heuvel, M. J., & Loozen, H. J. J. (1988) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(88)90007-6 · Cited by 44 · see citing works

Reversible suppression of menstruation with progesterone antagonists in rhesus macaques

Slayden, O. D. (2001) · Human Reproduction · doi:10.1093/humrep/16.8.1562 · Cited by 44 · see citing works

Estrogenic and progestagenic activities coexisting in steroidal drugs: Quantitative evaluation by In vitro bioassays with human cells

Markiewicz, L., & Gurpide, E. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90254-2 · Cited by 42 · see citing works

Human progesterone receptor A and B isoforms in CHO cells. II. Comparison of binding, transactivation and ed50 values of several synthetic (anti)progestagens in vitro in CHO and MCF-7 cells and in vivo in rabbits and rats

Schoonen, W. G. E. J., Dijkema, R., de Ries, R. J. H., Wagenaars, J. L., Joosten, J. W. H., de Gooyer, M. E., Deckers, G. H., & Kloosterboer, H. J. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)00161-1 · Cited by 41 · see citing works

Antiovulatory and postcoital antifertility activity of the antiprogestin CDB-2914 when administered as single, multiple, or continuous doses to rats

Reel, J. R., Hild-Petito, S. A., & Blye, R. P. (1998) · Contraception · doi:10.1016/s0010-7824(98)00067-5 · Cited by 40 · see citing works

RU486

Murphy, A. A., & Castellano, P. Ž. (1994) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/00001703-199406000-00012 · Cited by 39 · see citing works

Analysis of the relation between receptor binding affinity and antagonist efficacy of antiglucocorticoids

Gagne, D., Pons, M., & de Paulet, A. C. (1986) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(86)90242-6 · Cited by 39 · see citing works

Antagonist effect of RU 486 on transcription of glucocorticoid-regulated genes

Busso, N., Collart, M. A., Vassalli, J., & Belin, D. (1987) · Experimental Cell Research · doi:10.1016/0014-4827(87)90282-5 · Cited by 31 · see citing works

Biological potencies of chemically modified adrenocorticosteroids in rat and man

Ringler, I., West, K., Dulin, W. E., & Boland, E. W. (1964) · Metabolism · doi:10.1016/s0026-0495(64)80007-x · Cited by 27 · see citing works

Activation of pRL-TK by 12S E1A Oncoprotein: Drawbacks of Using an Internal Reference Reporter in Transcription Assays

Thavathiru, E., & Das, G. M. (2001) · BioTechniques · doi:10.2144/01313st06 · Cited by 22 · see citing works

Transcriptional regulation of the glycoprotein hormone α-subunit gene by pituitary adenylate cyclase-activating polypeptide (PACAP) in αT3-1 cells1This work was presented in part at the 10th International Congress of Endocrinology, 1996.1

Attardi, B., & Winters, S. J. (1998) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00006-9 · Cited by 17 · see citing works

Ulipristal Acetate versus Placebo for Fibroid Treatment before Surgery

Donnez, J., Татарчук, Т. Ф., Bouchard, P., Pușcașiu, L., Zakharenko, N. F., Ivanova, T. V., Ugocsai, G., Mára, M., Jilla, M. P., Bestel, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1103182 · Cited by 679 · see citing works

Ulipristal Acetate versus Leuprolide Acetate for Uterine Fibroids

Donnez, J., Tomaszewski, J., Vázquez, F., Bouchard, P., Lemieszczuk, B., Baró, F., Nouri, K., Selvaggi, L. E., Sodowski, K., Bestel, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1103180 · Cited by 604 · see citing works

Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications

Chabbert-Buffet, N., Meduri, G., Bouchard, P., & Spitz, I. M. (2005) · Human Reproduction Update · doi:10.1093/humupd/dmi002 · Cited by 310 · see citing works

Progesterone Receptor Modulator for Emergency Contraception

Creinin, M. D., Schlaff, W. D., Archer, D. F., Wan, L. S., Frezieres, R. G., Thomas, M. A., Rosenberg, M., & Higgins, J. (2006) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000239440.02284.45 · Cited by 230 · see citing works

Selective Progesterone Receptor Modulators—Mechanisms and Therapeutic Utility

Islam, M. S., Afrin, S., Jones, S. I., & Segars, J. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa012 · Cited by 143 · see citing works

Effects of the Progesterone Receptor Modulator VA2914 in a Continuous Low Dose on the Hypothalamic-Pituitary-Ovarian Axis and Endometrium in Normal Women: A Prospective, Randomized, Placebo-Controlled Trial

Chabbert‐Buffet, N., Pintiaux, A., & Bouchard, P. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2816 · Cited by 138 · see citing works

In vitro antiprogestational/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristone

Attardi, B., Burgenson, J., Hild, S. A., & Reel, J. R. (2004) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2003.12.004 · Cited by 124 · see citing works

A Novel Pathway Involving Progesterone Receptor, Endothelin-2, and Endothelin Receptor B Controls Ovulation in Mice

Palanisamy, G. S., Cheon, Y., Kim, J., Kannan, A., Li, Q., Sato, M., Mantena, S. R., Sitruk-Ware, R. L., Bagchi, M. K., & Bagchi, I. C. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0093 · Cited by 107 · see citing works

The MPA mouse breast cancer model: evidence for a role of progesterone receptors in breast cancer

Lanari, C., Lamb, C. A., Fabris, V. T., Helguero, L. A., Soldati, R., Bottino, M. C., Giulianelli, S., Cerliani, J. P., Wargon, V., & Molinolo, A. (2009) · Endocrine Related Cancer · doi:10.1677/erc-08-0244 · Cited by 103 · see citing works

Control of oocyte release by progesterone receptor-regulated gene expression

Robker, R. L., Akison, L. K., & Russell, D. L. (2009) · Nuclear Receptor Signaling · doi:10.1621/nrs.07012 · Cited by 103 · see citing works

Medical Treatments for Endometriosis-Associated Pelvic Pain

Zito, G., Luppi, S., Giolo, E., Martinelli, M., Venturin, I., Lorenzo, G. D., & Ricci, G. (2014) · BioMed Research International · doi:10.1155/2014/191967 · Cited by 94 · see citing works

Progesterone receptor modulator CDB-2914 down-regulates vascular endothelial growth factor, adrenomedullin and their receptors and modulates progesterone receptor content in cultured human uterine leiomyoma cells

Xu, Q. (2006) · Human Reproduction · doi:10.1093/humrep/del159 · Cited by 93 · see citing works

Comparison of progesterone and glucocorticoid receptor binding and stimulation of gene expression by progesterone, 17-alpha hydroxyprogesterone caproate, and related progestins

Attardi, B., Zeleznik, A. J., Simhan, H. N., Chiao, J. P., Mattison, D. R., & Caritis, S. N. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.05.024 · Cited by 89 · see citing works

Progesterone Receptor Modulator CDB-2914 Down-Regulates Proliferative Cell Nuclear Antigen and Bcl-2 Protein Expression and Up-Regulates Caspase-3 and Poly(Adenosine 5′-Diphosphate-ribose) Polymerase Expression in Cultured Human Uterine Leiomyoma Cells

Xu, Q., Takekida, S., Ohara, N., Chen, W., Sitruk-Ware, R. L., Johansson, E. D. B., & Maruo, T. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1569 · Cited by 87 · see citing works

Development of the selective progesterone receptor modulator CDB-2914 for clinical indications

Blithe, D., Nieman, L. K., Blye, R. P., Stratton, P., & Passaro, M. (2003) · Steroids · doi:10.1016/s0039-128x(03)00118-1 · Cited by 82 · see citing works

Cell-Type Specific Actions of Progesterone Receptor Modulators in the Regulation of Uterine Leiomyoma Growth

Yoshida, S., Ohara, N., Xu, Q., Chen, W., Wang, J., Nakabayashi, K., Sasaki, H., Morikawa, A., & Maruo, T. (2010) · Seminars in Reproductive Medicine · doi:10.1055/s-0030-1251483 · Cited by 82 · see citing works

Effects of ulipristal acetate on human embryo attachment and endometrial cell gene expression in an in vitro co-culture system

Berger, C., Boggavarapu, N. R., Menezes, J., Lalitkumar, P. G., & Gemzell‐Danielsson, K. (2015) · Human Reproduction · doi:10.1093/humrep/dev030 · Cited by 79 · see citing works

Uterine fibroids: an update on current and emerging medical treatment options

Farris, M., Bastianelli, C., Rosato, E., Brosens, I. A., & Benagiano, G. (2019) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s147318 · Cited by 82 · see citing works

Dimethandrolone Undecanoate: A New Potent Orally Active Androgen with Progestational Activity

Attardi, B., Hild, S. A., & Reel, J. R. (2006) · Endocrinology · doi:10.1210/en.2005-1524 · Cited by 80 · see citing works

Antiprogestins in breast cancer treatment: are we ready?

Lanari, C., Wargon, V., Rojas, P., & Molinolo, A. A. (2012) · Endocrine Related Cancer · doi:10.1530/erc-11-0378 · Cited by 75 · see citing works

Low-Dose Mifepristone Inhibits Endometrial Proliferation and Up-Regulates Androgen Receptor

Narvekar, N. N., Cameron, S. T., Critchley, H., Lin, S., Cheng, L., & Baird, D. T. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031945 · Cited by 74 · see citing works

Progesterone receptor isoforms, agonists and antagonists differentially reprogram estrogen signaling

Singhal, H., Greene, M. E., Zarnke, A. L., Lainé, M., Abosy, R. A., Chang, Y.-F., Dembo, A. G., Schoenfelt, K. Q., Vadhi, R., Qiu, X., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21378 · Cited by 73 · see citing works

Progesterone receptor modulator CDB-2914 induces extracellular matrix metalloproteinase inducer in cultured human uterine leiomyoma cells

Xu, Q., Ohara, N., Liu, J., Amano, M., Sitruk-Ware, R. L., Yoshida, S., & Maruo, T. (2008) · Molecular Human Reproduction · doi:10.1093/molehr/gan004 · Cited by 70 · see citing works

Endometrial changes from short-term therapy with CDB-4124, a selective progesterone receptor modulator

Ioffe, O. B., Zaino, R. J., & Mutter, G. L. (2009) · Modern Pathology · doi:10.1038/modpathol.2008.204 · Cited by 69 · see citing works

Inhibition of Proliferation of Endometrial Stromal Cells by Trichostatin A, RU486, CDB-2914, N-Acetylcysteine, and ICI 182780

Wu, Y., & Guo, S. (2006) · Gynecologic and Obstetric Investigation · doi:10.1159/000093975 · Cited by 66 · see citing works

Pharmacologic properties of CDB(VA)-2914

Gainer, E., & Ulmann, A. (2003) · Steroids · doi:10.1016/s0039-128x(03)00130-2 · Cited by 62 · see citing works

Ulipristal Acetate: Review of the Efficacy and Safety of a Newly Approved Agent for Emergency Contraception

Richardson, A. R., & Maltz, F. N. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.11.012 · Cited by 61 · see citing works

Macrophages and Immune Responses in Uterine Fibroids

Zannotti, A., Greco, S., Pellegrino, P., Giantomassi, F., Carpini, G. D., Goteri, G., Ciavattini, A., & Ciarmela, P. (2021) · Cells · doi:10.3390/cells10050982 · Cited by 60 · see citing works

Steroid hormonal regulation of growth, prostate specific antigen secretion, and transcription mediated by the mutated androgen receptor in CWR22Rv1 human prostate carcinoma cells

Attardi, B., Burgenson, J., Hild, S. A., & Reel, J. R. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2004.04.013 · Cited by 60 · see citing works

Effects of a novel estrogen-free, progesterone receptor modulator contraceptive vaginal ring on inhibition of ovulation, bleeding patterns and endometrium in normal women

Brache, V., Sitruk-Ware, R. L., Williams, A. R. W., Blithe, D., Croxatto, H. B., Kumar, N., Kumar, S., Tsong, Y. Y., Sivin, I., Nath, A., et al. (2011) · Contraception · doi:10.1016/j.contraception.2011.10.003 · Cited by 53 · see citing works

The selective progesterone receptor modulator CDB4124 inhibits proliferation and induces apoptosis in uterine leiomyoma cells

Luo, X., Yin, P., V., J. S. C., Cheng, Y.-H., Wiehle, R. D., & Bulun, S. E. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.11.031 · Cited by 49 · see citing works

Classical and Non-Classical Progesterone Signaling in Breast Cancers

Pedroza, D. A., Subramani, R., & Lakshmanaswamy, R. (2020) · Cancers · doi:10.3390/cancers12092440 · Cited by 48 · see citing works

New and emerging contraceptives: a state-of-the-art review

Bahamondes, L. G., & Bahamondes, M. V. (2014) · International Journal of Women s Health · doi:10.2147/ijwh.s46811 · Cited by 44 · see citing works

Emergency contraception: potential role of ulipristal acetate

Gemzell‐Danielsson, K. (2010) · International Journal of Women s Health · doi:10.2147/ijwh.s5865 · Cited by 46 · see citing works

Intrauterine administration of CDB-2914 (Ulipristal) suppresses the endometrium of rhesus macaques

Brenner, R., Slayden, O. D., Nath, A., Tsong, Y. Y., & Sitruk-Ware, R. L. (2009) · Contraception · doi:10.1016/j.contraception.2009.11.004 · Cited by 45 · see citing works

CDB-4124, a Progesterone Receptor Modulator, Inhibits Mammary Carcinogenesis by Suppressing Cell Proliferation and Inducing Apoptosis

Wiehle, R. D., Lantvit, D. D., Yamada, T., & Christov, K. T. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0244 · Cited by 43 · see citing works

Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA / PRB ratio via AIB 1 or SMRT recruitment to the CCND 1 and MYC promoters

Wargon, V., Riggio, M., Giulianelli, S., Sequeira, G. R., Rojas, P., May, M., Polo, M. L., Gorostiaga, M. A., Jacobsen, B. M., Molinolo, A., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29304 · Cited by 40 · see citing works

Anti-progestins suppress the growth of established tumors induced by 7,12-dimethylbenz(a)anthracene: Comparison between RU486 and a new 21-substituted-19-nor-progestin

Wiehle, R. D., Christov, K. T., & Mehta, R. G. (2007) · Oncology Reports · doi:10.3892/or.18.1.167 · Cited by 40 · see citing works

Mechanism of Action of Ulipristal Acetate for Emergency Contraception: A Systematic Review

Rosato, E., Farris, M., & Bastianelli, C. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00315 · Cited by 39 · see citing works

Progesterone receptor profile in the decidua and fetal membrane

Goldman, S. (2006) · Frontiers in bioscience · doi:10.2741/2088 · Cited by 39 · see citing works

Ulipristal Acetate Modulates the Expression and Functions of Activin A in Leiomyoma Cells

Ciarmela, P., Carrarelli, P., Islam, M. S., Janjusevic, M., Zupi, E., Tosti, C., Castellucci, M., & Petraglia, F. (2014) · Reproductive Sciences · doi:10.1177/1933719114542019 · Cited by 37 · see citing works

The activities of progesterone receptor isoform A and B are differentially modulated by their ligands in a gene‐selective manner

Leo, J. C. L., & Lin, V. C. L. (2007) · International Journal of Cancer · doi:10.1002/ijc.23081 · Cited by 37 · see citing works

Progesterone suppresses the fetal inflammatory response ex vivo

Schwartz, N., Xue, X., Elovitz, M. A., Dowling, O., & Metz, C. N. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.05.012 · Cited by 36 · see citing works

The effects of ulipristal on Bax/Bcl-2, cytochrome c, Ki-67 and cyclooxygenase-2 expression in a rat model with surgically induced endometriosis

Huniadi, C. A., Pop, O. L., Antal, T. A., & Stamatian, F. (2013) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2013.03.022 · Cited by 35 · see citing works

Pharmacokinetic evaluation of ulipristal acetate for uterine leiomyoma treatment

Melis, G. B., Piras, B., Marotto, M. F., Orrù, M., Maricosu, G., Pilloni, M., Guerriero, S., Angiolucci, M., Lello, S., & Paoletti, A. M. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.695775 · Cited by 35 · see citing works

Luteal phase dose-response relationships of the antiprogestin CDB-2914 in normally cycling women

Passaro, M. (2003) · Human Reproduction · doi:10.1093/humrep/deg342 · Cited by 34 · see citing works

The potent synthetic androgens, dimethandrolone (7α,11β-dimethyl-19-nortestosterone) and 11β-methyl-19-nortestosterone, do not require 5α-reduction to exert their maximal androgenic effects

Attardi, B., Hild, S. A., Koduri, S., Pham, T. C., Pessaint, L., Engbring, J. A., Till, B. A., Gropp, D., Semon, A., & Reel, J. R. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.06.009 · Cited by 34 · see citing works

Selective Progesterone Receptor Modulators in Early-Stage Breast Cancer: A Randomized, Placebo-Controlled Phase II Window-of-Opportunity Trial Using Telapristone Acetate

Lee, O., Sullivan, M. E., Xu, Y., Rogers, C., Muzzio, M., Helenowski, I., Shidfar, A., Zeng, Z., Singhal, H., Jovanovic, B. D., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0443 · Cited by 32 · see citing works

Novel, orally active selective progesterone receptor modulator CP8947 inhibits leiomyoma cell proliferation without adversely affecting endometrium or myometrium

Catherino, W. H., Malik, M., Driggers, P. H., Chappel, S. C., Segars, J. H., & Davis, J. B. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.05.005 · Cited by 31 · see citing works

Progesterone receptor antagonism inhibits progestogen-related carcinogenesis and suppresses tumor cell proliferation

Lee, O., Choi, M.-R., Christov, K. T., Ivancic, D. Z., & Khan, S. A. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.04.010 · Cited by 30 · see citing works

Influence of ulipristal acetate therapy compared with uterine artery embolization on fibroid volume and vascularity indices assessed by three-dimensional ultrasound: prospective observational study

Czuczwar, P., Woźniak, S., Szkodziak, P. R., Milart, P., Woźniakowska, E., Wrona, W., & Paszkowski, T. (2014) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.14668 · Cited by 29 · see citing works

Ulipristal acetate does not impact human normal breast tissue

Communal, L., Vilasco, M., Hugon‐Rodin, J., Courtin, A., Mourra, N., Lahlou, N., Dumont, S., Chaouat, M., Forgez, P., & Gompel, A. (2012) · Human Reproduction · doi:10.1093/humrep/des221 · Cited by 29 · see citing works

Ulipristal acetate administration at mid-cycle changes gene expression profiling of endometrial biopsies taken during the receptive period of the human menstrual cycle

Lira-Albarrán, S., Durand, M., Larrea-Schiavon, M. F., González, L., Barrera, D., Vega-García, C. C., Gamboa‐Domínguez, A., Rangel‐Escareño, C., & Larrea, F. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.02.024 · Cited by 29 · see citing works

Progesterone receptor blockade in human breast cancer cells decreases cell cycle progression through G2/M by repressing G2/M genes

Clare, S. E., Gupta, A., Choi, M.-R., Ranjan, M., Lee, O., Wang, J., Ivancic, D. Z., Kim, J. J., & Khan, S. A. (2016) · BMC Cancer · doi:10.1186/s12885-016-2355-5 · Cited by 28 · see citing works

Ulipristal Acetate: Critical Review About Endometrial and Ovulatory Effects in Emergency Contraception

Mozzanega, B., Gizzo, S., Gangi, S. D., Cosmi, E., & Nardelli, G. B. (2014) · Reproductive Sciences · doi:10.1177/1933719113519178 · Cited by 27 · see citing works

Mechanism of Telapristone Acetate (CDB4124) on Progesterone Receptor Action in Breast Cancer Cells

Davaadelger, B., Murphy, A. R., Clare, S. E., Lee, O., Khan, S. A., & Kim, J. J. (2018) · Endocrinology · doi:10.1210/en.2018-00559 · Cited by 25 · see citing works

Ulipristal Acetate Inhibits Progesterone Receptor Isoform A-Mediated Human Breast Cancer Proliferation and BCl2-L1 Expression

Esber, N., Billan, F. L., Resche-Rigon, M., Loosfelt, H., Lombès, M., & Chabbert‐Buffet, N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140795 · Cited by 25 · see citing works

Ulipristal Acetate

McKeage, K., & Croxtall, J. D. (2011) · Drugs · doi:10.2165/11207410-000000000-00000 · Cited by 24 · see citing works

Emerging drugs for endometriosis

Guo, S. (2008) · Expert Opinion on Emerging Drugs · doi:10.1517/14728210802548360 · Cited by 25 · see citing works

Progesterone receptor antagonists reverse stem cell expansion and the paracrine effectors of progesterone action in the mouse mammary gland

Ranjan, M., Lee, O., Cottone, G., Mehrabad, E. M., Spike, B. T., Zeng, Z., Yadav, S., Chatterton, R. T., Kim, J. J., Clare, S. E., et al. (2021) · Breast Cancer Research · doi:10.1186/s13058-021-01455-2 · Cited by 23 · see citing works

Ulipristal Acetate

Croxtall, J. D. (2012) · Drugs · doi:10.2165/11209400-000000000-00000 · Cited by 23 · see citing works

Resistance to cisplatin and paclitaxel does not affect the sensitivity of human ovarian cancer cells to antiprogestin-induced cytotoxicity

Gamarra-Luques, C. D., Hapon, M. B., Goyeneche, A. A., & Telleria, C. M. (2014) · Journal of Ovarian Research · doi:10.1186/1757-2215-7-45 · Cited by 23 · see citing works

The potential of selective progesterone receptor modulators for the treatment of uterine fibroids

Bestel, E., & Donnez, J. (2013) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2014.862495 · Cited by 22 · see citing works

Selective progesterone receptor modulators 1: use during pregnancy

Benagiano, G., Bastianelli, C., & Farris, M. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.14.2459 · Cited by 21 · see citing works

Progesterone receptor antagonist CDB-4124 increases depression-like behavior in mice without affecting locomotor ability

Beckley, E. H., Scibelli, A. C., & Finn, D. A. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.11.004 · Cited by 20 · see citing works

A single preovulatory administration of ulipristal acetate affects the decidualization process of the human endometrium during the receptive period of the menstrual cycle

Lira-Albarrán, S., Durand, M., Barrera, D., Vega-García, C. C., Garcı́a-Becerra, R., Dı́az, L., García‐Quiroz, J., Rangel‐Escareño, C., & Larrea, F. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.04.010 · Cited by 20 · see citing works

Environmental Pollutants Modulate Transcriptional Activity of Nuclear Receptors of Whales In Vitro

Lühmann, K., Lille‐Langøy, R., Øygarden, L., Kovacs, K. M., Lydersen, C., Goksøyr, A., & Routti, H. (2020) · Environmental Science & Technology · doi:10.1021/acs.est.9b06952 · Cited by 19 · see citing works

The progesterone-receptor modulator, ulipristal acetate, drastically lowers breast cell proliferation

Westhoff, C. L., Guo, H., Wang, Z., Hibshoosh, H. H., Polaneczky, M. M., Pike, M. C., & Ha, R. S. (2022) · Breast Cancer Research and Treatment · doi:10.1007/s10549-021-06503-1 · Cited by 19 · see citing works

Relative progestational and androgenic activity of four progestins used for male hormonal contraception assessed in vitro in relation to their ability to suppress LH secretion in the castrate male rat

Attardi, B., Koduri, S., & Hild, S. A. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.06.010 · Cited by 19 · see citing works

Population Pharmacokinetics of Telapristone (CDB-4124) and its Active Monodemethylated Metabolite CDB-4453, with a Mixture Model for Total Clearance

Morris, D., Podolski, J. S., Kirsch, A., Wiehle, R. D., & Fleckenstein, L. L. (2011) · The AAPS Journal · doi:10.1208/s12248-011-9304-7 · Cited by 18 · see citing works

The Selective Progesterone Receptor Modulator Ulipristal Acetate Inhibits the Activity of the Glucocorticoid Receptor

Small, B., Millard, C. E. F., Kisanga, E. P., Burman, A., Anam, A. K., Flannery, C. A., Al-Hendy, A. A., & Whirledge, S. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz139 · Cited by 17 · see citing works

Recent advances in structure of progestins and their binding to progesterone receptors

Cabeza, M., Heuze, Y., Sánchez, A., Garrido, M., & Bratoeff, E. (2014) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2014.895719 · Cited by 16 · see citing works

Mechanisms responsible for progesterone's protection against lordosis-inhibiting effects of restraint

Hassell, J. E., Miryala, C. S. J., Hiegel, C., & Uphouse, L. L. (2011) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.05.006 · Cited by 13 · see citing works

Ulipristal acetate in the management of symptomatic uterine fibroids: facts and pending issues

Pérez-López, F. R. (2014) · Climacteric · doi:10.3109/13697137.2014.981133 · Cited by 14 · see citing works

Ulipristal Acetate Antagonizes the Inhibitory Effect of Progesterone on Ciliary Beat Frequency and Upregulates Steroid Receptor Expression Levels in Human Fallopian Tubes

Yuan, J., Zhao, W., Yan, M., Zhu, Q., Qin, G.-J., Qiu, J., & Zhang, J. (2015) · Reproductive Sciences · doi:10.1177/1933719115589409 · Cited by 14 · see citing works

EllaOne®: a second-generation emergency contraceptive?

Mansour, D. (2009) · Journal of Family Planning and Reproductive Health Care · doi:10.1783/147118909789587141 · Cited by 14 · see citing works

UPA and LNG in emergency contraception: the information by EMA and the scientific evidences indicate a prevalent anti-implantation effect

Mozzanega, B., & Nardelli, G. B. (2019) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625187.2018.1555662 · Cited by 13 · see citing works

CDB-4124 Does Not Cause Apoptosis in Cultured Fibroid Cells

Roeder, H., Jayes, F. L., Feng, L., & Leppert, P. C. (2011) · Reproductive Sciences · doi:10.1177/1933719111399929 · Cited by 13 · see citing works

A Natural Mutation in Helix 5 of the Ligand Binding Domain of Glucocorticoid Receptor Enhances Receptor-Ligand Interaction

Reyer, H., Ponsuksili, S., Kanitz, E., Pöhland, R., Wimmers, K., & Muráni, E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164628 · Cited by 13 · see citing works

Lessons learned from the preclinical drug discovery of asoprisnil and ulipristal for non-surgical treatment of uterine leiomyomas

Maruo, T., Ohara, N., Yoshida, S., Nakabayashi, K., Sasaki, H., Xu, Q., Matsuo, H., Sitruk-Ware, R. L., & Yamada, H. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.602670 · Cited by 12 · see citing works

Characterisation of progestins used in hormonal contraception and progesterone via the progesterone receptor

Enfield, K., Cartwright, M., Toit, R. L.-D., Avenant, C., Africander, D., & Hapgood, J. P. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.09.058 · Cited by 12 · see citing works

Mechanism of action of bolandiol (19-nortestosterone-3β,17β-diol), a unique anabolic steroid with androgenic, estrogenic, and progestational activities

Attardi, B., Page, S. T., Hild, S. A., Coss, C. C., & Matsumoto, A. M. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.11.008 · Cited by 12 · see citing works

Selective progesterone receptor blockade prevents BRCA1-associated mouse mammary tumors through modulation of epithelial and stromal genes

Lee, O., Bosland, M. C., Wang, M., Shidfar, A., Hosseini, O., Xuei, X., Patel, P. A., Schipma, M. J., Helenowski, I., Kim, J. J., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.07.034 · Cited by 10 · see citing works

A novel approach for addressing diseases not yielding to effective vaccination? Immunization by replication-competent controlled virus

Voellmy, R. W., Bloom, D. C., & Vilaboa, N. E. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2015.1013941 · Cited by 10 · see citing works

Progesterone Receptor Isoforms, Nuclear Corepressor-1 and Steroid Receptor Coactivator-1 and B-Cell Lymphoma 2 and Akt and Akt Phosphorylation Status in Uterine Myomas after Ulipristal Acetate Treatment: A Systematic Immunohistochemical Evaluation

Courtoy, G. E., Donnez, J., Marbaix, É., Barreira, M., Luyckx, M., & Dolmans, M. (2017) · Gynecologic and Obstetric Investigation · doi:10.1159/000480011 · Cited by 10 · see citing works

Pharmacokinetics, toxicological and clinical aspects of ulipristal acetate: insights into the mechanisms implicated in the hepatic toxicity

Dinis‐Oliveira, R. J. (2021) · Drug Metabolism Reviews · doi:10.1080/03602532.2021.1917599 · Cited by 10 · see citing works

An antiprogestin, CDB4124, blocks progesterone's attenuation of the negative effects of a mild stress on sexual behavior

Uphouse, L. L., & Hiegel, C. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.11.002 · Cited by 8 · see citing works

The Translational Pharmacology of a Novel, Potent, and Selective Nonsteroidal Progesterone Receptor Antagonist, 2-[4-(4-Cyano-phenoxy)-3,5-dicyclopropyl-1 H-pyrazol-1-yl]-N-methylacetamide (PF-02367982)

Giorgio-Miller, A. D., Bungay, P. J., Tutt, M. F., Owen, J., Goodwin, D., & Pullen, N. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.140467 · Cited by 9 · see citing works

Approved Steroidal Drugs (2000–2025): A Medicinal Chemistry Perspective

Zhu, J., Luo, G., & Xiang, H. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c03005 · Cited by 8 · see citing works

Antiprogestins for breast cancer treatment: We are almost ready

Elia, A. M., Pataccini, G., Saldain, L., Ambrosio, L., Lanari, C., & Rojas, P. (2024) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2024.106515 · Cited by 8 · see citing works

Selective Progesterone Receptor Modulators (SPRMs) and Androgen Receptor Modulators (SARMs) as Treatment for Benign Gynecologic Diseases

Islam, M. S., Chen, L. W., & Segars, J. H. (2021) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000659 · Cited by 7 · see citing works

Phase III long‐term study to evaluate the efficacy and safety of ulipristal acetate in Japanese patients with uterine fibroids

Osuga, Y., Nakano, Y., Yamauchi, Y., & Murakawa, H. (2021) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.14802 · Cited by 6 · see citing works

Progesterone receptor isoform ratios influence the transcriptional activity of progestins via the progesterone receptor

Cartwright, M., Toit, R. L.-D., Jackson, H., van Vuuren, M. J., & Africander, D. (2023) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2023.106348 · Cited by 6 · see citing works

Ulipristal acetate: a new emergency contraceptive

Sullivan, J. L., & Bulloch, M. N. (2011) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.11.21 · Cited by 5 · see citing works

The transcriptional activity of progestins used in contraception and menopausal hormone therapy via progesterone receptor A is dependent on the density of the receptor

Cartwright, M., Toit, R. L.-D., & Africander, D. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.11.077 · Cited by 5 · see citing works

Effects of Antiprogestins on the Uterus

Ouzounian, S., Bouchard, P., & Chabbert‐Buffet, N. (2008) · Women s Health · doi:10.2217/17455057.4.3.269 · Cited by 5 · see citing works

Pathologic Changes in Uterine Leiomyomas After Extended Treatment With Ulipristal Acetate

Chang, M. C., & Latta, E. K. (2019) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0000000000000581 · Cited by 3 · see citing works

Ulipristal Acetate for Symptomatic Uterine Fibroids and Myoma-Related Hypermenorrhea Joint Statement by the German Society for Gynecological Endocrinology and Reproductive Medicine (DGGEF) and the German Professional Association of Gynecologists (BVF)

Rabe, T., Hj, A., Albring, C., Bitzer, J., Bouchard, P., Cirkel, U., Egarter, C., König, K., Harlfinger, W., Matzko, M., et al. (2013) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 3 · see citing works

The Medical Treatment of Uterine Fibroids

Olive, D. L. (2013) · Medical radiology · doi:10.1007/174_2013_850 · Cited by 2 · see citing works

The Translational Efficacy of a Nonsteroidal Progesterone Receptor Antagonist, 4-[3-Cyclopropyl-1-(mesylmethyl)-5-methyl-1H-pyrazol-4-yl]oxy,-2,6-dimethylbenzonitrile (PF-02413873), on Endometrial Growth in Macaque and Human

Howe, D. C., Mount, N. M., Bess, K., Brown, A., Bungay, P. J., Gibson, K. R., Hawcock, T., Richard, J., Jones, G., Walley, R. J., et al. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.183848 · Cited by 2 · see citing works

In vitro antiprogestational/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristone

Attardi, B., Burgenson, J., Hild, S. A., & Reel, J. R. (2004) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2003.12.004 · Cited by 124 · see citing works

CDB-2914: Anti-progestational/anti-glucocorticoid profile and post-coital anti-fertility activity in rats and rabbits

Hild, S. A. (2000) · Human Reproduction · doi:10.1093/humrep/15.4.822 · Cited by 46 · see citing works

Luteal phase dose-response relationships of the antiprogestin CDB-2914 in normally cycling women

Passaro, M. (2003) · Human Reproduction · doi:10.1093/humrep/deg342 · Cited by 34 · see citing works

Binding affinity of mifepriston to progesterone and glucocorticoid receptors

Ya-l, B. (2005) · Shandong yiyao

New analogues of mifepristone with more dissociated antiprogesterone activities

Philibert, D., Hardy, M., Gaillard-Moguilewsky, M., Nique, F., Tournemine, C., & Nédélec, L. (1989) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(89)90118-0 · Cited by 21 · see citing works